Volume 5 Supplement 1
Proceedings of the 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)
Meeting abstracts
12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Go to conference site.
Bethesda, MD, USA26-27 April, 2010
Page 1 of 2
-
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A1
-
AIDS-related Kaposi’s sarcoma: outcomes after initiation of highly active antiretroviral therapy under routine conditions in Zimbabwe
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A2 -
AIDS-related lymphomas in Nigeria an emerging phenomenon
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A3 -
An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A4 -
Attitude of health care providers in Abia State, Nigeria, to people living with HIV and AIDS
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A5 -
Bacteria-mediated reactivation of gammaherpesviruses
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A6 -
Bim nuclear translocation and inactivation by HHV-8 interferon regulatory factor 1
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A7 -
C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A8 -
Cervical cancer epidemiology among HIV-infected women in North America
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A9 -
Challenges in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan, Côte d’Ivoire
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A10 -
Characterization of lytic human herpesvirus-8 gene expression in Kaposi sarcoma tumor tissue and its clinical correlates
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A11 -
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A12 -
Current epidemiology of KSHV infection in American men who have sex with men
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A13 -
Cutaneous squamous cell carcinoma in HIV-infected patients: a report of two (2) cases
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A14 -
Cytosine methylation in the HPV16 3’ L1/ 5’LCR region characterized from anal epithelia of HPV-HIV coinfected men
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A15 -
Delay in anal cancer diagnosis as a non-AIDS-defining malignancy
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A16 -
Detection and quantitation of HPV in anogenital and oral tissues and fluids of HIV-positive individuals by real-time PCR
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A17 -
Development of a proteomic platform for EBV and KSHV serological screening
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A18 -
Diagnosis of HIV-related malignancies in resource-constrained settings of sub-Saharan Africa, a cautionary tale for non-Hodgkin’s lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A19 -
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A20 -
DNA ploidy, cell proliferation, and HIV/EBV association in Tanzanian malignant lymphomas
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A21 -
Do people with AIDS develop cancer at younger ages than the general population?
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A22 -
EBV-induced miR-34a functions to stimulate transformed B cell growth
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A23 -
Elevated serum levels of CXCL13 precede HIV-associated non-Hodgkin’s lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A24 -
Elevated serum levels of heat shock protein 70 precede the development of AIDS-non-Hodgkin lymphoma in carriers of the common and highly conserved HLA-B8-DR3 haplotype
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A25 -
Epidemiology of malignancies in HIV patients at Kamuzu Central Hospital in Lilongwe, Malawi
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A26 -
Epigenetic deregulation of IGF2 and cervical cancer precursors in HIV+ and HIV- patients
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A27 -
Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A28 -
Gamma-tubulin and 53BP1 as candidate biomarkers of human papillomavirus-associated anal dysplasia
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A29 -
HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A30 -
High acceptance rate of anal pap screening despite limited knowledge about anal dysplasia among HIV+ MSM
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A31 -
HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A32 -
HIV-associated salivary gland disease: a role for BK birus
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A33 -
HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence, outcome, and evolution of CD4+ T cell lymphocytes
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A34 -
HPV genotype and EGFR activation in conjunctival carcinoma among HIV patients in East Africa
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A35 -
Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A36 -
Human herpesvirus type 8 variants in Kaposi's sarcoma before and after AIDS era
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A37 -
Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A38 -
Immunohistochemically confirmed HHV-8-related lymphoproliferative disorders in Uganda
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A39 -
Inhibition of KSHV-associated lymphoma engraftment in SCID mouse by morpholino oligomers
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A40 -
Initial experience with topical fluorouracil (5-FU) for treatment of anal intraepithelial neoplasia (AIN) in HIV-positive patients
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A41 -
Integrative proteomics and genomics supports a role for interferon gamma in the pathogenesis of Kaposi sarcoma and finds multiple candidate diagnostic proteins for early detection or prevention
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A42 -
Kaposi sarcoma in South African children
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A43 -
Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A44 -
Kaposi’s sarcoma-associated herpesvirus ORF57 promotes escape of viral and human IL6 RNAs from microRNA-mediated suppression
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A45 -
Knowledge of HPV and cervical cancer among HIV-positive women in Lagos, Nigeria
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A46 -
KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman's disease
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A47 -
KSHV interaction with Langerhans and dermal dendritic cells through C-type lectins
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A48 -
KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi's sarcoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A49 -
KSHV regulation of fibulins in Kaposi's sarcoma: implications for tumorigenesis
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A50
-
Affiliated with
-
Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.1
5-year Journal Impact Factor: 3.3
Source Normalized Impact per Paper (SNIP): 0.810
SCImago Journal Rank (SJR): 0.424Speed 2023
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 112Usage 2023
Downloads: 687,750
Altmetric mentions: 813
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.